Barr K, Laine R A, Lester R L
Biochemistry. 1984 Nov 6;23(23):5589-96. doi: 10.1021/bi00318a032.
From the yeast phase of the human pathogen Histoplasma capsulatum, three novel glycolipids were isolated, shown to react with sera from histoplasmosis patients, and partially characterized: compound V, ceramide-P-inositol-[mannose2]; compound VI, ceramide-P-inositol-[mannose2, galactose]; compound VIII, an isomer of compound VI [Barr, K., & Lester, R.L. (1984) Biochemistry (preceding paper in this issue)]. Ammonolysis of these lipids has yielded all the carbohydrate (oligosaccharides V, VI, and VIII) as novel, intact oligosaccharides suitable for characterization. Anomeric configurations were determined by specific glycosidase digestion and by the stability of peracetylated saccharides to CrO3 oxidation. Linkages were established by methylation analysis. These experiments yielded the following structural assignments: (formula; see text) The occurrence of galactofuranose is novel for glycosphingolipids, and it is noteworthy that compound VI is immunoreactive.
从人类病原体荚膜组织胞浆菌的酵母相中,分离出三种新型糖脂,它们被证明能与组织胞浆菌病患者的血清发生反应,并进行了部分表征:化合物V,神经酰胺 - P - 肌醇 - [甘露糖₂];化合物VI,神经酰胺 - P - 肌醇 - [甘露糖₂,半乳糖];化合物VIII,化合物VI的异构体[巴尔,K.,& 莱斯特,R.L.(1984年)《生物化学》(本期之前的论文)]。这些脂质的氨解反应产生了所有的碳水化合物(寡糖V、VI和VIII),作为适合表征的新型完整寡糖。异头构型通过特定糖苷酶消化以及全乙酰化糖类对CrO₃氧化的稳定性来确定。连接方式通过甲基化分析确定。这些实验得出了以下结构归属:(分子式;见正文)呋喃半乳糖的出现对于鞘糖脂来说是新颖的,值得注意的是化合物VI具有免疫反应性。